GSK to produce paediatric vaccines at new Chinese joint venture
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline is to set up a joint venture with the Chinese company Jiangsu Walvax Biotech for the development and manufacture of paediatric vaccines, initially GSK's measles, mumps and rubella (MMR) vaccine Priorix.